Thrombosis in Cushing's disease; raising the flag of concern.
ACTH-secreting pituitary adenoma
Disease management
Endocrine surgical procedures
Pituitary ACTH hypersecretion
Systematic review
Thrombosis
Journal
Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181
Informations de publication
Date de publication:
06 Jan 2023
06 Jan 2023
Historique:
received:
15
08
2022
accepted:
24
12
2022
revised:
11
12
2022
entrez:
5
1
2023
pubmed:
6
1
2023
medline:
10
1
2023
Statut:
epublish
Résumé
Cushing's disease (CD) is associated with an increased risk of venous thromboembolic events. The purpose of this review is to discuss preventive strategies for post-operative thrombosis in CD patients and their impact on patient outcomes. A systematic review under PRISMA guidelines was conducted within PubMed, Embase, Web of Science, and Cochrane databases through July 2022. Of the 3207 papers retrieved, seven articles were included in this systematic review. Four hundred forty-eight patients were presented in the reviewed studies and the overall reported mortality was 2.67% (12/448). Three studies utilized prophylaxis methods including graduated compression stockings (GCS) and early ambulation (EA) while the remaining four studies only used anticoagulation medicine. Only 20 patients received pre-operative prophylactic treatment, while 366 patients received post-operative prophylaxis which was delivered either immediately after surgery or at different time intervals within 2 days following the surgery. Thrombotic events mainly occurred within two to 3 months after surgery. Overall, a higher frequency of thromboembolic events and mortality was observed in the control groups in comparison to groups receiving prophylaxis. A combination of anticoagulation, EA, and GCS might reduce thrombotic events and mortality in CD patients after treatment. Although the early commencement of a prophylactic anticoagulation regimen on the same day of surgery and continuing up to 3 months seems beneficial, the application of a prophylactic regimen should be utilized with caution since the number of included studies was insufficient to draw a strong conclusion, as well as neither prospective study nor randomized controlled trials existed.
Identifiants
pubmed: 36604392
doi: 10.1007/s10143-022-01941-x
pii: 10.1007/s10143-022-01941-x
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
32Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Buliman A, Tataranu L, Paun D, Mirica A (2016) Dumitrache C. Cushing’s disease: A multidisciplinary overview of the clinical features, diagnosis, and treatment J Med Life 9(1):12
Smith TR, Hulou MM, Huang KT, Nery B, de Moura SM, Cote DJ et al (2015) Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas. Neurosurgical focus 38(2):E12
Sabahi M, Shahbazi T, Maroufi SF, Vidal K, Recinos PF, Kshettry VR et al (2022) MRI-negative Cushing's disease: A review on therapeutic management. World Neurosurgery
Sharifi G, Amin AA, Sabahi M, Echeverry NB, Dilmaghani NA, Mousavinejad SA et al (2022) MRI-negative Cushing’s Disease: Management Strategy and Outcomes in 15 Cases Utilizing a Pure Endoscopic Endonasal Approach. BMC Endocrine Disorders 22(1):1–11
Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G et al (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783–91
Jackson JA, Trowbridge A, Smigiel M (1990) Fatal pulmonary thromboembolism after successful transsphenoidal hypophysectomy for Cushing's disease. South Med J 83(8):960–2
Soni P, Koech H, Silva D, Das P, Sindwani R, Dobri G et al (2020) Cerebral venous sinus thrombosis after transsphenoidal resection: A rare complication of cushing disease-associated hypercoagulability. World Neurosurg 134:86–9
Barbot M, Daidone V, Zilio M, Albiger N, Mazzai L, Sartori MT et al (2015) Perioperative thromboprophylaxis in Cushing’s disease: what we did and what we are doing? Pituitary 18(4):487–93
Suarez MG et al (2020) Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc 4(2):bvz033
doi: 10.1210/jendso/bvz033
Sharma ST, Nieman LK, Feelders RA (2015) Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol 7:281–93
Small M, Lowe GD, Forbes CD, Thomson JA (1983) Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 19(4):503–11
Wijewickrama PSA, Ratnasamy V, Somasundaram NP, Sumanatilleke M, Ambawatte SB (2021) A challenging case of Cushing’s disease complicated with multiple thrombotic phenomena following trans-sphenoidal surgery; a case report. BMC Endocr Disord 21(1):1–7
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–9
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34
Wilkins T, Gillies RA, Davies K (2005) EMBASE versus MEDLINE for family medicine searches: can MEDLINE searches find the forest or a tree? Canadian Family Physician 51(6):848–9
Obuobie K, Davies JS, Ogunko A, Scanlon MF (2000) Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest 23(8):542–4
Miao Z, Zhang Z, Chen J, Wang J, Zhang H, Lei T (2018) Cerebral venous sinus thrombosis following second transsphenoidal surgery: report of a rare complication and review of literature. World Neurosurg 110:101–5
Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT et al (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. J Clin Endocrinol Metab 87(8):3662–6
Jitaroon K, Song SH, Chang MT, Wongworawut Y, Ibrahim N, Fernandez-Miranda JC et al (2020) DVT/PE rates and etiologies after endoscopic/endoscopic-assisted skull base surgery. Journal of Neurological Surgery Part B: Skull Base 81(S 01):A027
Van Zaane B, Stuijver DJ, Squizzato A, Gerdes VE(2013) Arterial and venous thrombosis in endocrine diseases. Semin Thromb Hemost 39(5):489–95
Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M (2019) Hypercoagulability and risk of venous thromboembolic events in endogenous cushing's syndrome: a systematic meta-analysis. Frontiers in Endocrinology 9:805
Kastelan D, Dusek T, Kraljevic I, Polasek O, Giljevic Z, Solak M et al (2009) Hypercoagulability in cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine 36(1):70–4
Van der Pas R, de Bruin C, Leebeek FW, de Maat MP, Rijken DC, Pereira AM et al (2012) The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab 97(4):1303–10
Haak HR, Caekebeke-Peerlinck KM, van Seters AP, Briët E (1991) Prolonged bleeding time due to mitotane therapy. Eur J Cancer 27(5):638–41
Steinhilber D, Jaschonek K, Knospe J, Morof O, Roth HJ (1990) Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. Arzneimittelforschung 40(11):1260–3
Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S et al (2018) Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. Eur J Endocrinol 178(4):399–409
Carmalt MH, Dalton GA, Fletcher RF, Smith WT (1977) The treatment of Cushing's disease by trans-sphenoidal hypophysectomy. Q J Med 46(181):119–34
Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Girolami A (1982) Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost 47(2):116–
Smith TR, Habib A, Rosenow JM, Nahed BV, Babu MA, Cybulski G et al (2015) Defensive medicine in neurosurgery: does state-level liability risk matter? Neurosurgery 76(2):105–14
Lang F, Gawaz M, Borst O (2015) The serum‐& glucocorticoid‐inducible kinase in the regulation of platelet function. Acta physiologica 213(1):1815–90
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing's syndrome: state of the art. The lancet Diabetes & endocrinology 4(7):611–29
Coelho MC, Santos CV, Vieira Neto L, Gadelha MR (2015) Adverse effects of glucocorticoids: coagulopathy. Eur J Endocrinol 173(4):M11-21
Dekkers OM, Horváth-Puhó E, Jørgensen JOL, Cannegieter SC, Ehrenstein V, Vandenbroucke JP et al (2013) Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. The Journal of Clinical Endocrinology & Metabolism 98(6):2277–84
Laws ER, Aguiar PH (2008) Vascular complications in transsphenoidal surgery. JBNC-JORNAL BRASILEIRO DE NEUROCIRURGIA 19(3):7–14
Oskouian RJ, Kelly DF, Edward Jr R (2006) Vascular injury and transsphenoidal surgery. Pituitary Surgery-A Modern Approach 34:256–78
Koutroumpi S, Daidone V, Sartori M, Cattini M, Albiger N, Occhi G et al (2013) Venous thromboembolism in patients with Cushing’s syndrome: need of a careful investigation of the prothrombotic risk profile. Pituitary 16(2):175–81
Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev (7):Cd001484
Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S-e77S
Casonato A, Pontara E, Boscaro M, Sonino N, Sartorello F, Ferasin S et al (1999) Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis 10(3):145–51
Kastelan D, Dusek T, Kraljevic I, Aganovic I (2013) Hypercoagulable state in cushing's syndrome is reversible following remission. Clinical endocrinology 78(1):102–6
Fleseriu M, Biller B, Grossman A, Swearingen B, Melmed S, editors (2017) on behalf of the Pituitary Society International Cushing Disease Workshop Task Force. Hypercoagulability in Cushing disease: a risk awareness and prophylaxis survey on behalf of the Pituitary Society. 15th International Pituitary Congress